24 October 2023 - Potential to be the first and only self-administered flu vaccine. ...
20 October 2023 - The FDA’s decision is based on data from Phase 2 and Phase 3 trials, which demonstrated that ...
18 October 2023 - Full authorisation of prototype enables rapid authorisation of updated Novavax COVID-19 vaccines in future. ...
16 October 2023 - European Union regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the ...
12 October 2023 - MimiVax announced today that the US FDA has granted fast track designation to MimiVax’s SurVaxM vaccine ...
8 October 2023 - From 1 November 2023, older Australians will have free access to the best protection against shingles through ...
3 October 2023 - Today, the US FDA amended the emergency use authorisation of the Novavax COVID-19 vaccine, adjuvanted for use ...
28 September 2023 - Spikevax XBB.1.5 approved for persons aged 18 and over ...
28 September 2023 - The updated vaccine is expected to be available in Canada in the coming weeks. ...
20 September 2023 - It has been just over a week since the US FDA and the US Centers for ...
15 September 2023 - The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and ...
18 September 2023 - The Ministry of Health has released a summary of the New Zealand Government’s procurement process for ...
14 September 2023 - EMA’s human medicines committee (CHMP) has recommended authorising an adapted Spikevax vaccine targeting the Omicron XBB.1.5 ...
12 September 2023 - Health Canada has authorised the use of the Moderna Spikevax COVID-19 vaccine targeting the Omicron XBB.1.5 ...
7 September 2023 - Milestone signifies on-going effort to help prepare for outbreaks of Zaire ebolavirus. ...